Cspc baike shandong biopharmaceutical co ltd
WebJun 16, 1992 · CSPC, founded in June, 1992 and headquartered in Shijiazhuang, is a biopharmaceutical developer. The founder is Cai Dongchen. Listed on the HKEX on … http://cspcbaike.en.drugdu.com/company_profile.html
Cspc baike shandong biopharmaceutical co ltd
Did you know?
WebCSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the … WebDec 26, 1994 · Address: No.212 Jinbu Street Qinshui South Korean Industrial Park Muping District, Yantai City, Shandong, P.R. China; Website: www.cspcbaike.com
WebJul 24, 2024 · August 3, 2024 updated by: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. A Single-center, Open-label, Controlled Clinical Study to Evaluate the Efficacy and Safety of Jinyouli®(PEG-rhG-CSF) for the Recovery of Neutropenia After Chemotherapy in Patients With Hemophagocytic Syndrome WebCSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd. Company Profile Yantai, Shandong, China Competitors, Financials & Contacts - Dun & Bradstreet. Find …
WebJul 24, 2024 · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Collaborator. Beijing Friendship Hospital; Provider of Information About this Clinical Study Sponsor; Overall Official(s) ... ID Number: CSPC-JYL-HLH-01. NCT Identifier: NCT04500886. NCT04500886, March 29, 2024. http://cspc.com.br/
WebFind company research, competitor information, contact details & financial data for CSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd. of Yantai, Shandong. Get the latest business insights from Dun & Bradstreet.
WebJun 13, 2016 · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Study record dates These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being … list object has no attribute cellWebJan 9, 2024 · January 20, 2024 updated by: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Prospective, Open, One-arm Clinical Study Evaluating the Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced … list object has no attribute join python 3Webmonthly return of equity issuer on movements in securities for the month ended 31 march 2024 list object foreach java 8WebOct 24, 2024 · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Save Print Send. Updated on 24 October 2024. See if I qualify. Summary. Show definitions ... list object has no attribute join pythonWebJul 27, 2024 · August 2, 2024 updated by: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. A Multi-center, Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of the Prophylactic Use of Pegylated Recombinant Human Granulocyte Colony Stimulating Factor After Chemotherapy in Children With Hematological Malignancies list object has no attribute keys csvWebApr 26, 2024 · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Investigators None specified. Study Documents (Full-Text) None provided. More Information Publications None provided. Responsible Party: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. ClinicalTrials.gov Identifier: NCT04855292. Other Study ID Numbers: SYSA1803-CSP … list object has no attribute divWebMay 23, 2024 · CSPC Baike, Shandong, Biopharmaceutical Co., Ltd (Sponsor) Clinical Trials, 17 Results, Page 1 17 Clinical Trials Sponsored by CSPC Baike, Shandong, … list object has no attribute min